Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Workman

Showing results (61-70 of 315) with videos related to

Pageof 32
Sort By:
Trends in Biotechnology|April 3, 2009
Structure-based design of molecular cancer therapeuticsRob L M van Montfort, Paul Workman
Cancer Cell|May 19, 2010
Unveiling the secrets of the ancestral PI3 kinase Vps34Paul Workman, Rob L M van Montfort
Nature Chemical Biology|January 19, 2010
PI(3) kinases: revealing the delta ladyPaul Workman, Rob L M van Montfort
Molecular Oncology|March 24, 2012
Discovery of small molecule cancer drugs: successes, challenges and opportunitiesSwen Hoelder, Paul A Clarke, Paul Workman
Oncotarget|September 12, 2012
Shock about heat shock in cancerEmmanuel de Billy, Jon Travers, Paul Workman
Nature Biotechnology|July 12, 2012
Combinatorial drug therapy for cancer in the post-genomic eraBissan Al-Lazikani, Udai Banerji, Paul Workman
The Biochemical Journal|February 23, 2008
The Hsp90 molecular chaperone: an open and shut case for treatmentLaurence H Pearl, Chrisostomos Prodromou, Paul Workman
Methods in Molecular Medicine|December 6, 2003
Bioreductive prodrugs for cancer therapyBeatrice Seddon, Lloyd R Kelland, Paul Workman
Essays in Biochemistry|November 10, 2017
Structure-based drug design: aiming for a perfect fitRob L M van Montfort, Paul Workman
Breast Cancer Research : BCR|July 9, 2002
Finding the needle in the haystack: why high-throughput screening is good for your healthG Wynne Aherne, Edward McDonald, Paul Workman
Pageof 32

Showing results (61-70 of 315) with videos related to

Sort By:
Pageof 32
Trends in Biotechnology|April 3, 2009
Structure-based design of molecular cancer therapeuticsRob L M van Montfort, Paul Workman
Cancer Cell|May 19, 2010
Unveiling the secrets of the ancestral PI3 kinase Vps34Paul Workman, Rob L M van Montfort
Nature Chemical Biology|January 19, 2010
PI(3) kinases: revealing the delta ladyPaul Workman, Rob L M van Montfort
Molecular Oncology|March 24, 2012
Discovery of small molecule cancer drugs: successes, challenges and opportunitiesSwen Hoelder, Paul A Clarke, Paul Workman
Oncotarget|September 12, 2012
Shock about heat shock in cancerEmmanuel de Billy, Jon Travers, Paul Workman
Nature Biotechnology|July 12, 2012
Combinatorial drug therapy for cancer in the post-genomic eraBissan Al-Lazikani, Udai Banerji, Paul Workman
The Biochemical Journal|February 23, 2008
The Hsp90 molecular chaperone: an open and shut case for treatmentLaurence H Pearl, Chrisostomos Prodromou, Paul Workman
Methods in Molecular Medicine|December 6, 2003
Bioreductive prodrugs for cancer therapyBeatrice Seddon, Lloyd R Kelland, Paul Workman
Essays in Biochemistry|November 10, 2017
Structure-based drug design: aiming for a perfect fitRob L M van Montfort, Paul Workman
Breast Cancer Research : BCR|July 9, 2002
Finding the needle in the haystack: why high-throughput screening is good for your healthG Wynne Aherne, Edward McDonald, Paul Workman
Pageof 32